feed,title,long_url,short_url
Benzinga,"Analyst Cuts Freeline Therapeutics' Price Target As Gaucher Program Takes Center Stage, Fabry Program Exits",https://benzinga.com/general/biotech/23/04/31684440/analyst-cuts-freeline-therapeutics-price-target-as-gaucher-program-takes-center-stage-fabry-progr,https://da.gd/WYCt
Benzinga,Crypto Clash In Texas: Will Senate Bill Crush The State's Bitcoin Gold Rush?,https://benzinga.com/markets/cryptocurrency/23/04/31680366/crypto-clash-in-texas-will-senate-bill-crush-the-states-bitcoin-gold-rush,https://da.gd/E3ZVu
